Skip to content
MedsAcross

Medicine

Cleviprex 25 mg/50 mL injectable emulsion

Clevidipine · Intravenous · Chiesi
Available on requestPrescription onlyUS FDA Cold chain

Cleviprex 25 mg/50 mL injectable emulsion is a prescription medicine containing Clevidipine for intravenous use, marketed by Chiesi, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store vials refrigerated at 2-8°C (36-46°F). Do not freeze. Upon transfer to…

Key facts

Active ingredient (INN)
Clevidipine
Brand
Cleviprex
Strength
25 mg/50 mL
Dosage form
Injectable emulsion
Route
Intravenous
Packs
10 cartons of 50 mL
Marketing authorisation holder
Chiesi
Manufacturers
ChiesiFresenius Kabi Austria
Origin register
US FDA, United States
Storage
Store vials refrigerated at 2-8°C (36-46°F). Do not freeze. Upon transfer to room temperature, mark vials in cartons “This product was removed from the refrigerator on _/_/_ date. Vials in cartons may be transferred to 25°C (77°F, USP controlled room temperature) for a period not to exceed 2 months.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C08CA16 Clevidipine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 September 2008
Identifiers
RxCUI 1790239, 1790242, 1790245 +3DailyMed set ID f9290625-b723-4eda-bab8-a97bef6041f6, a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330NDC 10122-610, 18124-011Application NDA022156

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
10 carton in 1 carton / 1 vial, single-use in 1 carton / 50 mL in 1 vial, single-use10122-610-10Chiesi15 September 2008
10 carton in 1 carton / 1 vial, single-use in 1 carton / 50 mL in 1 vial, single-use18124-011-50Fresenius Kabi Austria15 September 2008

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 1 August 2008Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Clevidipine

Clinical summary

Clevidipine is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. It is available as injectable emulsion for intravenous use. MedsAcross supplies Clevidipine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Clevidipine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Cleviprex 25 mg/50 mL injectable emulsion for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.